ACArnab Chowdhury

Arnab Chowdhury

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Arnab Chowdhury has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    An efficient method for site-selective boronation of peptides and proteins applied in magnified bacterial imaging

    by Saurav Chatterjee, Arnab Chowdhury, Neelam Verma, Sneha Basa, Nitesh Mani Tripathi, Vinod Gour, Vishal Rai, Anupam Bandyopadhyay

    Borylated compounds have received tremendous attention in chemical biology and drug design. Motivated by this notion, we develop an efficient methodology for boron incorporation into peptides and proteins via chemoselective conjugation of cysteine residues under catalyst-, additive-, and metal-free conditions. By harnessing the optimum SN2 displacement profile of bromomethyl boronate, we establish a methodology that enables the selective incorporation of methylboronic acid into various peptides, including bioactive constructs, as well as proteins with rapid kinetics (>102 M-1s-1) and excellent conversions at physiological pH. The method also leverages rapid access to bivalent boron conjugates, which, when applied to clinically used antimicrobial peptide UBI(29-41), augment its binding efficacy (40-fold) via covalent capture of the diols on bacterial surface glycans, mainly wall teichoic acid (and thus lipoteichoic acid). Notably, bis-boronated UBI exhibits selective staining of S. aureus over gram-negative bacteria and mammalian cells, alongside a 14-fold increase in serum half-life compared to native UBI.


  • Introducing the Potential Binding Interface between the TRAIL-Mimicking Peptide and DR5 via Alanine Scan

    by Nitesh Mani Tripathi, Arnab Chowdhury, Neelam Verma, Anupam Bandyopadhyay

    Here we harnessed the unexplored binding interface between the 16-residue peptide (P) agonist and death receptor 5 (DR5). P is a solitary peptide ligand that mimics TRAIL (the natural ligand to death receptor) and is reported to control cancer growth in vivo selectively. We delved into the strategic merging of experimental and in silico structure–activity studies via the alanine scanning mutagenesis of P, wherein the disulfide bond was kept intact for structural integrity. Antiproliferative activity studies with these synthetic mutants on HCT116 cells enabled the mapping of the interaction engagement of each residue. Further, in silico docking and MD simulations led us to interpret and model the 3D interface of the binding site. Notably, Trp1, Leu4, Arg7, Ile8, Gln12, and Arg15 were projected experimentally as “hot-spot” residues crucial for primary interactions with DR5, which is predominantly supported via in silico investigations. This study is pivotal for developing new-generation peptide agonists that induce death receptor-mediated apoptosis.


  • Open Access

    Introducing Regioselective Disulfide Linkages in Peptides under Pseudodilute Conditions by Harnessing Bro̷nsted Acid-Activated N-Chlorosuccinimide

    by Nitesh Mani Tripathi, Basab Kanti Das, Arnab Chowdhury, Vinod Gour, Anupam Bandyopadhyay

    Methods that assemble multiple peptide disulfide bonds in the solid phase (pseudodilute conditions) are in high demand for synthesizing disulfide-rich peptides. Yet, the existing repertoire of disulfide-forming orthogonal chemistries in the solid phase is often hindered by additional steps for protecting group removals as well as the absolute necessity of rare, customized orthogonal cysteine (Cys) building blocks. We now describe a conceptually new while operationally simple on-resin method for disulfide assembly with widely accessible Cys protecting groups (Trt, Acm, and t Bu) using acid-activated N-chlorosuccinimide (NCS) in a single step. In the process, S- t Bu Cys emerged as a new orthogonal building block for the single-step assembly of the peptide disulfide. In our investigations, 2% TFA-activated NCS offered rapid (∼15 min) and a clean disulfide product in various peptides. Eventually, this novel strategy (2% TFA-NCS) was strategically merged in stepwise cross-linking with our previously described I2/S2O8 2--mediated disulfide assembly protocol to leverage two regioselective disulfide bonds into conotoxin, gomesin, and a de novo sequence within ∼30 min. Invariably, this new method proved highly productive and operationally simple. DFT calculations also support the hypothesis of NCS activation that assists efficient disulfide assembly in crossing a low-lying energy barrier via sulfonium intermediates. This newly developed method for t Bu deprotection and concomitant disulfide assembly in the solid phase should find wide applications in de novo peptide disulfide synthesis.


  • Introducing Chemoselective Peptide Conjugation via N-Alkylation of Pyridyl-alanine: Solution and Solid Phase Applications

    by Soumit Dutta, Arnab Chowdhury, Anupam Bandyopadhyay

    A novel chemoselective peptide conjugation via late-stage N-alkylation of pyridyl-alanine (PAL) in the solution and solid phase, namely, NAP, is demonstrated. The method constructs functionally diverse and highly stable N-alkylated conjugates with various peptides. Notably, conjugations in the solid phase offered a more economical process. The method can provide the opportunity for dual labeling along with a cysteine handle in a peptide chain. Finally, we showcased that the antiproliferative activities of the p53 peptide (MDM2 inhibitor) could be 2-fold enhanced via NAP conjugation with the RGD peptide (selective integrin binder).


  • Open Access

    Harnessing a bis-electrophilic boronic acid lynchpin for azaborolo thiazolidine (ABT) grafting in cyclic peptides

    by Basab Kanti Das, Arnab Chowdhury, Saurav Chatterjee, Nitesh Mani Tripathi, Bibekananda Pati, Soumit Dutta, Anupam Bandyopadhyay

    Chemical modifications of native peptides have significantly advanced modern drug discovery in recent decades. On this front, the installation of multitasking molecular grafts onto macrocyclic peptides offers numerous opportunities in biomedical applications. Here, we showcase a new class of borono-cyclic peptides featuring an azaborolo thiazolidine (ABT) graft, which can be readily assembled utilizing a bis-electrophilic boronic acid lynchpin while harnessing the inherent reactivity difference (>103 M−1 s−1) between the N-terminal cysteine and backbone cysteine for rapid and highly regioselective macrocyclization (∼1 h) under physiological conditions. The ABT-crosslinked peptides are fairly stable in endogenous environments, but can provide the linear diazaborine peptides via treatment with α-nucleophiles. This efficient peptide crosslinking protocol was further extended for regioselective bicyclizations and engineering of α-helical structures. Finally, ABT-grafted peptides were exploited in biorthogonal conjugation, leading to highly effective intracellular delivery of an apoptotic peptide (KLA) in cancer cells. The mechanism of action by which ABT-grafted KLA peptide induces apoptosis was also explored.


  • On-resin synthesis of Lanreotide epimers and studies of their structure–activity relationships

    by Arnab Chowdhury, Nitesh Mani Tripathi, Rohit Jadav, Vinod Gour, Parva Purohit, Anupam Bandyopadhyay

    Peptide drugs often accompany epimeric impurities (isomers). Therefore, efficient chemical synthesis of epimers is critical to identify them correctly and investigate their biological activities. Here, we report the rapid synthesis and structure–activity relationship (SAR) studies of eight possible epimers of a somatostatin synthetic analog (SSA), lanreotide (LAN). SPPS and the subsequent on-resin rapid disulfide closure method offered >90% conversion yield for all epimers (P1–P8). Further, we developed an analytical method to separate these epimers, which enabled the profiling of five epimeric impurities in the API, purchased for Somatuline generic formulations. In SAR studies, most LAN epimers revealed compromised antiproliferative activity, while the P7 epimer retained antiproliferative activity similar to LAN API, as supported by in silico SAR studies in detail. Additionally, P7 showed serum stability nearly identical to LAN, suggesting that drug epimers could be a potential API. Current studies will further encourage the development of novel SSA scaffolds.


  • Design and synthesis of novel quinazolinone-based pyruvate kinase M2 activators as selective inhibitors of oral cancer cells

    by Bhagyashri Rathod, Swarali Joshi, Siddulu Regu, K.V.N.S. Manikanta, Hansal Kumar, Samdisha Dubey, Arnab Chowdhury, Raisa Parveen Shaikh, Anwesha Das, Sagarkumar Patel, et al.


  • Rapid and Highly Productive Assembly of a Disulfide Bond in Solid-Phase Peptide Macrocyclization

    by Arnab Chowdhury, Vinod Gour, Basab Kanti Das, Saurav Chatterjee, Anupam Bandyopadhyay

    Here we report a highly efficient disulfide-driven peptide macrocyclization in 15 min on a solid support using persulfate as a crucial additive in iodine-mediated oxidative cyclization. The method eliminates the side products of classical iodine-mediated peptide cyclization. It is operationally simple and convenient for cyclizing small to lengthier peptides embodying popular cysteine building blocks in a single step.


  • A perspective on environmentally benign protocols of thiazole synthesis

    by Arnab Chowdhury, Sagarkumar Patel, Ayushi Sharma, Anwesha Das, Payal Meshram, Amit Shard